ArticleArchives of medical science : AMS2025

Development and validation of a pathological model predicting the efficacy of neoadjuvant therapy for breast cancer based on RCB scoring.

Huan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.